Vantage logo

A new reality for Immunocore

A private raise should crystallise what was already known to have been a valuation comedown for Immunocore and its troubled investor Neil Woodford.

Vantage logo

Medtech VC and the billion-dollar era

The first one-shot billion-dollar venture investment round in the medical technology sector has gone to Verily as computing bleeds into medicine.